Jounce Therapeutics, Inc. Debt to Equity Ratio 2017-2022 | JNCE
Current and historical debt to equity ratio values for Jounce Therapeutics, Inc. (JNCE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Jounce Therapeutics, Inc. debt/equity for the three months ending December 31, 2022 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-12-31 |
$0.03B |
$0.18B |
0.16 |
2022-09-30 |
$0.03B |
$0.13B |
0.22 |
2022-06-30 |
$0.03B |
$0.16B |
0.20 |
2022-03-31 |
$0.03B |
$0.19B |
0.14 |
2021-12-31 |
$0.03B |
$0.22B |
0.13 |
2021-09-30 |
$0.03B |
$0.25B |
0.12 |
2021-06-30 |
$0.03B |
$0.28B |
0.10 |
2021-03-31 |
$0.03B |
$0.28B |
0.09 |
2020-12-31 |
$0.03B |
$0.21B |
0.16 |
2020-09-30 |
$0.03B |
$0.11B |
0.29 |
2020-06-30 |
$0.03B |
$0.13B |
0.25 |
2020-03-31 |
$0.03B |
$0.15B |
0.20 |
2019-12-31 |
$0.03B |
$0.18B |
0.18 |
2019-09-30 |
$0.03B |
$0.19B |
0.16 |
2019-06-30 |
$0.10B |
$0.09B |
1.12 |
2019-03-31 |
$0.12B |
$0.09B |
1.26 |
2018-12-31 |
$0.11B |
$0.10B |
1.06 |
2018-09-30 |
$0.13B |
$0.10B |
1.27 |
2018-06-30 |
$0.15B |
$0.11B |
1.33 |
2018-03-31 |
$0.17B |
$0.11B |
1.50 |
2017-12-31 |
$0.13B |
$0.17B |
0.78 |
2017-09-30 |
$0.14B |
$0.18B |
0.81 |
2017-06-30 |
$0.16B |
$0.18B |
0.92 |
2017-03-31 |
$0.18B |
$0.18B |
1.03 |
2016-12-31 |
$0.20B |
$0.07B |
2.88 |
2016-09-30 |
$0.00B |
|
0.00 |
2016-06-30 |
$0.00B |
|
0.00 |
2016-03-31 |
$0.00B |
|
0.00 |